drugset / Trial / NCT03610893

Dexamethasone Versus Dexmedetomidine as Adjuvants for Nerve Blocks

NCT03610893 ↗

Completed 120 enrolled University of Chile
RandomizedParallel-groupTriple-blindTreatment

Summary

When used as perineural (PN) adjuvants to local anesthetics (LAs), dexamethasone (DX) and dexmedetomidine (DXD) have been well documented to prolong the duration of peripheral nerve blocks. These drugs have important differences in terms of cost and safety profiles. This randomized controlled trial (RCT) will compare PN DX and PN DXD for ultrasound-guided infraclavicular brachial plexus blocks (ICBs). Since analgesic and sensory duration can be influenced by factors different to block, motor block duration is the main outcome. The protocol is designed as an equivalency trial and hypothesize that both drugs result in similar durations. The equivalency margin is set at 3 hrs.

Timeline

Start
2018-08-16
Primary completion
2019-04-30
Completion
2019-04-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 5 mg Other
Comparator Dexmedetomidine Other / unclassified 100 ug Other

Indications

No indication recorded.